Stoke Therapeutics Inc.

STOK | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.77

+$0.72 (+2.57%)

Sep 22, 2026, 10:13 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	84.22M	127.98M	191.44M	113.56M	144.9M	287.31M
Short-Term Investments	200.45M	88.92M	9.95M	116.04M	74.92M	n/a
Long-Term Investments	n/a	29.82M	n/a	n/a	n/a	n/a
Other Long-Term Assets	106.49M	721K	569K	569K	569K	205K
Receivables	7.91M	700K	64K	588K	132K	6K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.39M	4.04M	2.56M	2.96M	2.33M	181K
Total Current Assets	305.7M	232.76M	215.34M	244.07M	229.22M	293.93M
Property-Plant & Equipment	6.25M	8.25M	12.43M	11.43M	9.08M	3.79M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	112.73M	38.8M	13M	12M	9.65M	4M
Total Assets	418.43M	271.56M	228.34M	256.07M	238.87M	297.93M
Account Payables	4.94M	2.5M	1.7M	766K	2.39M	1.5M
Deferred Revenue	11.9M	18.99M	15.31M	14.88M	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	15.04M	8.44M	6.47M	6.26M	5.92M	4.58M
Total Current Liabilities	57.88M	40.06M	30.82M	31.39M	17.14M	11.43M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.14M	26K	4.88M	2.97M	417K	422K
Total Long-Term Liabilities	8.1M	2.48M	37.96M	39.82M	3.95M	422K
Total Liabilities	65.98M	42.53M	68.78M	71.22M	21.09M	11.85M
Total Debt	3.01M	4.77M	2.06M	2.36M	5.04M	1.07M
Book Value	352.46M	229.02M	159.57M	184.85M	217.78M	286.08M
Book Value Per Share	5.95	4.24	3.63	4.75	5.93	8.54
Common Stock	5K	5K	5K	4K	4K	4K
Retained Earnings	-497.72M	-490.83M	-401.85M	-297.15M	-196.08M	-110.28M
Comprehensive Income	543K	-151K	-24K	-1.18M	-168K	n/a
Shareholders Equity	352.46M	229.02M	159.57M	184.85M	217.78M	286.08M
Total Investments	200.45M	118.74M	9.95M	116.04M	74.92M	n/a